Weiss Multi-Strategy Advisers’s GSK GSK Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,622	Closed	-$200K	–	607
2023 Q2	$200K	Sell	5,622 -108,736	-95%	-$3.9M	﹤0.01%	605
2023 Q1	$4.07M	Sell	114,358 -50,177	-30%	-$1.76M	0.1%	298
2022 Q4	$5.78M	Buy	+164,535	New	+$5.48M	0.16%	196
2017 Q4	–	Sell	-44,800	Closed	-$2.27M	–	599
2017 Q3	$2.27M	Hold	44,800	–	–	0.08%	291
2017 Q2	$2.42M	Sell	44,800 -800	-2%	-$42.6K	0.1%	257
2017 Q1	$2.4M	Hold	45,600	–	–	0.1%	246
2016 Q4	$2.19M	Buy	45,600 +20,000	+78%	+$988K	0.11%	188
2016 Q3	$1.38M	Sell	25,600 -644	-2%	-$35.3K	0.09%	262
2016 Q2	$1.42M	Sell	26,244 -13,756	-34%	-$725K	0.11%	224
2016 Q1	$2.03M	Hold	40,000	–	–	0.09%	261
2015 Q4	$2.02M	Buy	40,000 +20,000	+100%	+$1.02M	0.14%	173
2015 Q3	$961K	Buy	+20,000	New	+$1.04M	0.04%	274

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GSK Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of GSK (GSK) in Q3 2023, closing a stake of 5,622 shares — an estimated $200K sold.

Weiss Multi-Strategy Advisers first reported a position in GSK in Q3 2015 and held it in 12 quarters. The position peaked at $5.78M in Q4 2022. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

Weiss Multi-Strategy Advisers reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 5,622 GSK shares in Q3 2023, an estimated $200K.
Weiss Multi-Strategy Advisers first reported a position in GSK in Q3 2015 and held it in 12 quarters.
Weiss Multi-Strategy Advisers's GSK position peaked at $5.78M in Q4 2022.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.